Conventional Karyotyping and Fluorescence In Situ Hybridization for Detection of Chromosomal Abnormalities in Multiple Myeloma
Journal of Hematology · 2022
DOI: 10.14740/jh1007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hematology, 2022. Verfasst von Matthew Crabtree und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Harbor-UCLA Medical Center, Torrance, CA 90502, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
ORCID-Profile: Matthew Crabtree, Jennifer Cai, Xin Qing
Zitieren
APA
Crabtree, M., Cai, J., & Qing, X. (2022). Conventional Karyotyping and Fluorescence In Situ Hybridization for Detection of Chromosomal Abnormalities in Multiple Myeloma. Journal of Hematology. https://doi.org/10.14740/jh1007
Vancouver
Crabtree M, Cai J, Qing X. Conventional Karyotyping and Fluorescence In Situ Hybridization for Detection of Chromosomal Abnormalities in Multiple Myeloma. Journal of Hematology. 2022. doi:10.14740/jh1007
BibTeX
@article{Crabtree2022,
author = {Crabtree, Matthew and Cai, Jennifer and Qing, Xin},
title = {Conventional Karyotyping and Fluorescence In Situ Hybridization for Detection of Chromosomal Abnormalities in Multiple Myeloma},
journal = {Journal of Hematology},
year = {2022},
doi = {10.14740/jh1007}
}
EUVIMED